fda warning letter semaglutide october 2025 to FDA's Office of Prescription Drug Promotion, CDER – Partnership for Safe Medicines FDA warns Novo Nordisk over

[6] A boxed warning exists for thyroid C-cell tumors

Older adults or those with slower metabolic rates may experience slightly prolonged drug duration

For the safest and most effective experience, always consult with our professionals to receive personalized recommendations and to determine the ideal duration of your Semaglutide GLP-1 weight loss program

Every Vial Size at a Glance Across the six vial sizes sold most often, these are the standard reconstitution volumes

A pivotal aspect of GLP-1 agonists is their favorable safety profile

While WellSyncs platform can work alongside any marketing agency or channel, it has a preferred agency partner that deeply understands the GLP-1 landscape